Walled Lake Planning & Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Walled Lake Planning & Wealth Management's NVS Position: Q1 2026 in Review
Walled Lake Planning & Wealth Management increased its Novartis (NVS) stake by 0.75% in Q1 2026, buying an estimated $56.7K and bringing the position to 50,002 shares worth $7.64M. The position accounts for 2.24% of the portfolio, ranked #12.
Walled Lake Planning & Wealth Management first reported a position in NVS in Q1 2022 and has held it in 17 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Walled Lake Planning & Wealth Management held 50,002 shares of Novartis worth $7.64M as of Q1 2026.
- Walled Lake Planning & Wealth Management bought 370 Novartis shares in Q1 2026, an estimated $56.7K.
- Novartis made up 2.24% of Walled Lake Planning & Wealth Management's portfolio in Q1 2026, its #12 holding.
- Walled Lake Planning & Wealth Management first reported a position in Novartis in Q1 2022 and has held it in 17 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Walled Lake Planning & Wealth Management's 13F filing for Q1 2026, filed 30 Apr 2026.